Why don't we have effective treatments for Alzheimer's disease? Are diseases such as malaria "too little money"? Who, today, can and should bear the costs and risks of effective therapeutic innovation? It is around these crucial questions, and the developments and trends in the field of therapeutic innovation at the start of the 21st century, that Prof. Bernard Meunier has built his reflections and his year of lectures.
Published on 31 October 2014
Thursday, November 6, 2014 at 6 p.m
-
Collège de France
Amphithéâtre Marguerite de Navarre
11 place Marcelin-Berthelot
75005 Paris
Lectures will take place on Mondays at 4 pm, starting November 17, 2014.